STERIS Corporate — Segment operating income increased by 3.5% to -$106.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.2%, from -$100.80M to -$106.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in corporate operating expenses may indicate rising administrative overhead or strategic investments in central infrastructure, while a decrease often reflects successful cost-containment initiatives or improved corporate efficiency.
This metric represents the operating expenses and administrative costs associated with the company's central corporate f...
Most large-cap medical technology companies report similar unallocated corporate costs, though the magnitude varies based on the company's organizational structure and the degree to which central costs are pushed down to operating segments.
ste_segment_corporate_segment_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$77.27M | -$79.50M | -$62.36M | -$75.94M | -$67.06M | -$53.87M | -$91.87M | -$87.02M | -$81.56M | -$101.75M | -$97.10M | -$100.80M | -$109.90M | -$106.00M |
| QoQ Change | — | -2.9% | +21.6% | -21.8% | +11.7% | +19.7% | -70.5% | +5.3% | +6.3% | -24.8% | +4.6% | -3.8% | -9.0% | +3.5% |
| YoY Change | — | — | — | +1.7% | +15.6% | +13.6% | -21.0% | -29.8% | -51.4% | -10.7% | -11.6% | -23.6% | -13.2% | -5.2% |